Rain Oncology Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. Thank you for joining us for the 41st JPMorgan Healthcare Conference. We're thrilled to have you here, and we're thrilled to have Rain Oncology. We've got Avanish Vellanki here, who's going to -- President and CEO of Rain, who's going to kick us off.
Thanks, James. Thanks, everyone. It's a pleasure to be here. We want to thank the conference organizers and our friends at JPMorgan for allowing us to share our story today. My name is Avanish Vellanki, Co-Founder and CEO of Rain Oncology. Before we get started on a more lighthearted note, and given the weather that we're having in San Francisco, I think it's forced upon us to explain the name, Rain. And so let me tell you the story. In 2017, when I incorporated the company, California was in the midst of a drought. And as far as the eye could see, it was just different shades of brown, everything was dying and patches of dirt where the grass used to be, and so it's really dawned on me how much of a need
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |